English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/177211
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders

AuthorsZeinolabediny, Yasmin; Caccuri, Francesca; Colombo, Laura; Morelli, Federica; Romeo, Margherita; Rossi, Alessandro; Schiarea, Silvia; Ciaramelli, Carlotta; Airoldi, Cristina; Weston, Ria; Donghui, Liu; Krupinski, Jerzy; Corpas, Rubén CSIC ORCID; García-Lara, Elisa; Sarroca, Sara CSIC; Sanfeliu, Coral CSIC ORCID; Slevin, Mark; Caruso, Arnaldo; Salmona, Mario; Diomede, Luisa
Issue Date4-Sep-2017
PublisherNature Publishing Group
CitationScientific Reports 7:10313 (2017)
AbstractHuman immunodeficiency virus type-1 (HIV-1)-associated neurocognitive disorder (HAND) remains an important neurological manifestation that adversely affects a patient’s quality of life. HIV-1 matrix protein p17 (p17) has been detected in autoptic brain tissue of HAND individuals who presented early with severe AIDS encephalopathy. We hypothesised that the ability of p17 to misfold may result in the generation of toxic assemblies in the brain and may be relevant for HAND pathogenesis. A multidisciplinary integrated approach has been applied to determine the ability of p17 to form soluble amyloidogenic assemblies in vitro. To provide new information into the potential pathogenic role of soluble p17 species in HAND, their toxicological capability was evaluated in vivo. In C. elegans, capable of recognising toxic assemblies of amyloidogenic proteins, p17 induces a specific toxic effect which can be counteracted by tetracyclines, drugs able to hinder the formation of large oligomers and consequently amyloid fibrils. The intrahippocampal injection of p17 in mice reduces their cognitive function and induces behavioral deficiencies. These findings offer a new way of thinking about the possible cause of neurodegeneration in HIV-1-seropositive patients, which engages the ability of p17 to form soluble toxic assemblies.
Publisher version (URL)https://doi.org/10.1038/s41598-017-10875-0
Appears in Collections:(IIBB) Artículos
Files in This Item:
File Description SizeFormat 
HIV-1_ Zeinolabediny.pdf3,05 MBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.